1. Sparsentan in immunoglobulin A nephropathy: a profile of its use

   • Young-A Heo
   • Connie Kang

   Adis Drug Q&A 29 March 2024 Pages: 101 - 108

2. Treat bipolar depression with atypical antipsychotics and mood stabilisers; new therapies require further study

   • Simon Fung

   Practical Issues and Updates 11 March 2024 Pages: 109 - 114

3. Get on top of gout with a fresh look at treatment options

   • Caroline Fenton
   • Connie Kang

   Practical Issues and Updates 04 April 2024 Pages: 115 - 120

4. Treating paediatric Crohn’s disease is challenging but new treatments hold promise

   • Tina Nie

   Disease Management 28 March 2024 Pages: 121 - 126

5. Be aware of the risks of nephrotoxicity when prescribing amoxicillin and third-generation cephalosporins

   • Amy Zhuang-Yan

   Drug Reactions and Interactions 21 March 2024 Pages: 127 - 130

6. What is the role of pioglitazone for patients with type 2 diabetes in value-based care settings?

   • Andrea Bush
   • Tina Benny
   • Matthew Seamon

   Current Opinion 28 March 2024 Pages: 131 - 136

   

7. Correction to: Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use

   • Tina Nie

   Correction Open access 21 March 2024 Pages: 137 - 137

8. Correction to: Efanesoctocog alfa in hemophilia A: a profile of its use

   • Simon Fung
   • Hannah A. Blair

   Correction Open access 21 March 2024 Pages: 138 - 138